All News

Colleen McCabe, PharmD, BCOP, emphasizes the importance of a proactive and tailored approach for pharmacists educating patients on skin cancer risks specific to their communities.

Type 1 diabetes (T1D), which once predominantly affected children, is increasingly affecting older adults in the US, with prevalence rates peaking in those aged 45 to 64, according to recent research.

The company’s version of the opioid overdose medication will be $10 cheaper than branded products and is set to be available in stores later this month.

Cutting through the noise of social media is key when educating patients on how to make better choices for their skin.

Different weight loss therapies provide a wide range of benefits to patients with T1D—but they have some potential adverse effects.

Dynavax plans to meet with the FDA to discuss how the company can provide additional data to support the approval of its 4-dose Heplisav-B regimen and expand protection for adults with end-stage renal disease (ESRD) on hemodialysis.

Warm weather means one thing: People are eager to be outdoors. Although sun protection is paramount, sunscreen options can be daunting. How can pharmacists help?

For Melanoma and Skin Cancer Awareness Month, Drug Topics sat down with Colleen McCabe, PharmD, BCOP, to glean clinical insights into promoting skin cancer awareness in the community pharmacy.

During World Asthma Day on May 7, advocacy groups for asthma awareness addressed the need for better worldwide education.

Study results suggest a nationwide increase in the supply and availability of illicitly manufactured fentanyl, with pills becoming more dominant across the ever-shifting US fentanyl market.

In Germany, data live in the cloud, patients can fill prescriptions at any pharmacy, and the wholesale price of semaglutide (Ozempic) is a fraction of the cost.

In case you missed it, this week we had news about pharmacy issues in the election spotlight, advancements in psychedelic therapeutics, prior authorization, and more.

Check out a recap of important pharmacy news you might’ve missed this week, dispensed in small doses.

Check out important updates from the FDA for the week of May 6.

The company, which operates 140 care sites across the country, was forced to shut down health systems earlier this week because of the disruption.

Test your pharmacy news knowledge with our weekly quiz.

Dive in and learn more about the answers to yesterday’s quiz.

Since biosimilars first launched, unique pricing incentives and strategies have been created to incentives adoption.

A single dose of Compass Pathways’ investigational COMP360 was well tolerated and showed durable improvements in CAPS-5 and SDS total scores compared to baseline.

Tandem Diabetes Care, Inc has reported 224 injuries associated with a software malfunction in a companion insulin app, leading the company to issue a recall of the technology.

Researchers analyzed the prior authorization requirements of private insurers applied to various Medicare services.

Test your knowledge of allergy and asthma clinical guidelines.

Designs of existing wearables overlook the specific needs of vulnerable populations, hindering their widespread adoption among increasingly interested communities.

Check out this list of resources to share with patients who are experiencing mental health conditions.

With the mental health crisis worsening in the United States, recent research explores novel treatments and underlying causes.

As demand for GLP-1 receptor agonist medications increases, researchers are hopeful these drugs can be used for more indications than those that currently exist.

Last August, zuranolone (Zurzuvae) became the first FDA-approved pill to treat postpartum depression in adults.

Spring and summer not only bring sunshine, but also stronger UV rays. Whether you are barbecuing, swimming, or taking a hike, skin protection is paramount while soaking up the sunshine.